Michael L. Ritchey

Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

Paul E. Grundy, Norman E. Breslow, Sierra Li et al. · Journal of Clinical Oncology · 2005 · 471 citations · Full text

Medicine, Genetics, Oncology +17

Treatment of Anaplastic Histology Wilms' Tumor: Results From the Fifth National Wilms' Tumor Study

Jeffrey S. Dome, Cecilia A. Cotton, Elizabeth J. Perlman et al. · Journal of Clinical Oncology · 2006 · 346 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Surgery-Related Factors and Local Recurrence of Wilms Tumor in National Wilms Tumor Study 4

Robert C. Shamberger, Katherine A. Guthrie, Michael L. Ritchey et al. · Annals of Surgery · 1999 · 312 citations

Medicine, Oncology, Surgery +16

Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.

D. M. Green, N. E. Breslow, J. Bruce Beckwith et al. · Journal of Clinical Oncology · 1998 · 307 citations

Medicine, Oncology, Pharmacotherapy +15

END STAGE RENAL DISEASE IN PATIENTS WITH WILMS TUMOR: RESULTS FROM THE NATIONAL WILMS TUMOR STUDY GROUP AND THE UNITED STATES RENAL DATA SYSTEM

Norman E. Breslow, Allan J. Collins, Michael L. Ritchey et al. · The Journal of Urology · 2005 · 266 citations · Full text

Medicine, Nephrology, Oncology +12